(AEM) Agnico Eagle Mines - Overview
Stock: Gold, Silver, Zinc, Copper
| Risk 5d forecast | |
|---|---|
| Volatility | 46.5% |
| Relative Tail Risk | -0.45% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.21 |
| Alpha | 128.91 |
| Character TTM | |
|---|---|
| Beta | 0.283 |
| Beta Downside | 0.137 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.99% |
| CAGR/Max DD | 2.82 |
EPS (Earnings per Share)
Revenue
Description: AEM Agnico Eagle Mines January 28, 2026
Agnico Eagle Mines Ltd. (NYSE:AEM) is a vertically integrated gold producer that also extracts silver, zinc, and copper. The firm operates four primary mines in Canada, Australia, Finland, and Mexico, and maintains a broad exploration footprint spanning North America, Europe, and Australia. Incorporated in 1953, the company is headquartered in Toronto, Canada.
In its FY-2023 results released in February 2024, Agnico Eagle produced 2.6 million ounces of gold, a 3 % increase YoY, while maintaining an all-in sustaining cost (AISC) of US$1,030 per ounce-below the industry median of roughly US$1,200. Cash flow from operations reached US$2.1 billion, supporting a dividend yield of ~2.1 % and a net debt-to-EBITDA ratio of 0.4×, indicating a strong balance sheet.
The company’s performance is tightly linked to macro-level gold price dynamics. As of 28 Jan 2026, spot gold trades near US$2,050/oz, driven by persistent inflation, accommodative monetary policy, and heightened geopolitical risk-factors that historically boost safe-haven demand. Additionally, supply-side constraints from declining mine grades and limited new project pipelines keep upward pressure on prices, benefitting producers with low-cost operations like Agnico Eagle.
For a deeper quantitative assessment of AEM’s valuation and risk profile, a quick look at the ValueRay platform can surface comparable peer metrics and scenario-based forecasts.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 4.45b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 5.70 > 1.0 |
| NWC/Revenue: 21.25% < 20% (prev 15.71%; Δ 5.54% < -1%) |
| CFO/TA 0.34 > 3% & CFO 11.55b > Net Income 4.45b |
| Net Debt (-2.51b) to EBITDA (5.66b): -0.44 < 3 |
| Current Ratio: 2.02 > 1.5 & < 3 |
| Outstanding Shares: last quarter (500.0m) vs 12m ago -0.34% < -2% |
| Gross Margin: 60.84% > 18% (prev 0.42%; Δ 6042 % > 0.5%) |
| Asset Turnover: 36.82% > 50% (prev 27.45%; Δ 9.37% > 0%) |
| Interest Coverage Ratio: 36.91 > 6 (EBITDA TTM 5.66b / Interest Expense TTM 120.3m) |
Altman Z'' 4.65
| A: 0.07 (Total Current Assets 4.99b - Total Current Liabilities 2.47b) / Total Assets 34.47b |
| B: 0.18 (Retained Earnings 6.05b / Total Assets 34.47b) |
| C: 0.14 (EBIT TTM 4.44b / Avg Total Assets 32.23b) |
| D: 2.54 (Book Value of Equity 24.75b / Total Liabilities 9.73b) |
| Altman-Z'' Score: 4.65 = AA |
Beneish M -3.97
| DSRI: 0.07 (Receivables 18.7m/189.6m, Revenue 11.87b/8.23b) |
| GMI: 0.69 (GM 60.84% / 41.80%) |
| AQI: 1.01 (AQ_t 0.19 / AQ_t-1 0.19) |
| SGI: 1.44 (Revenue 11.87b / 8.23b) |
| TATA: -0.21 (NI 4.45b - CFO 11.55b) / TA 34.47b) |
| Beneish M-Score: -3.97 (Cap -4..+1) = AAA |
What is the price of AEM shares?
Over the past week, the price has changed by +5.39%, over one month by +9.17%, over three months by +44.25% and over the past year by +135.78%.
Is AEM a buy, sell or hold?
- StrongBuy: 9
- Buy: 7
- Hold: 3
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the AEM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 241.8 | 5.9% |
| Analysts Target Price | 241.8 | 5.9% |
AEM Fundamental Data Overview February 18, 2026
P/E Forward = 17.301
P/S = 8.9475
P/B = 4.6257
P/EG = 28.1515
Revenue TTM = 11.87b USD
EBIT TTM = 4.44b USD
EBITDA TTM = 5.66b USD
Long Term Debt = 196.3m USD (from longTermDebt, last quarter)
Short Term Debt = 62.2m USD (from shortTermDebt, two quarters ago)
Debt = 357.8m USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = -2.51b USD (calculated as Total Debt 357.8m - CCE 2.87b)
Enterprise Value = 104.04b USD (106.55b + Debt 357.8m - CCE 2.87b)
Interest Coverage Ratio = 36.91 (Ebit TTM 4.44b / Interest Expense TTM 120.3m)
EV/FCF = 23.60x (Enterprise Value 104.04b / FCF TTM 4.41b)
FCF Yield = 4.24% (FCF TTM 4.41b / Enterprise Value 104.04b)
FCF Margin = 37.15% (FCF TTM 4.41b / Revenue TTM 11.87b)
Net Margin = 37.48% (Net Income TTM 4.45b / Revenue TTM 11.87b)
Gross Margin = 60.84% ((Revenue TTM 11.87b - Cost of Revenue TTM 4.65b) / Revenue TTM)
Gross Margin QoQ = 73.50% (prev 56.57%)
Tobins Q-Ratio = 3.02 (Enterprise Value 104.04b / Total Assets 34.47b)
Interest Expense / Debt = 12.89% (Interest Expense 46.1m / Debt 357.8m)
Taxrate = 34.27% (794.1m / 2.32b)
NOPAT = 2.92b (EBIT 4.44b * (1 - 34.27%))
Current Ratio = 2.02 (Total Current Assets 4.99b / Total Current Liabilities 2.47b)
Debt / Equity = 0.01 (Debt 357.8m / totalStockholderEquity, last quarter 24.74b)
Debt / EBITDA = -0.44 (Net Debt -2.51b / EBITDA 5.66b)
Debt / FCF = -0.57 (Net Debt -2.51b / FCF TTM 4.41b)
Total Stockholder Equity = 23.10b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.80% (Net Income 4.45b / Total Assets 34.47b)
RoE = 19.25% (Net Income TTM 4.45b / Total Stockholder Equity 23.10b)
RoCE = 19.05% (EBIT 4.44b / Capital Employed (Equity 23.10b + L.T.Debt 196.3m))
RoIC = 12.34% (NOPAT 2.92b / Invested Capital 23.64b)
WACC = 6.97% (E(106.55b)/V(106.90b) * Re(6.96%) + D(357.8m)/V(106.90b) * Rd(12.89%) * (1-Tc(0.34)))
Discount Rate = 6.96% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.30%
[DCF Debug] Terminal Value 84.71% ; FCFF base≈3.49b ; Y1≈4.31b ; Y5≈7.34b
Fair Price DCF = 318.2 (EV 156.69b - Net Debt -2.51b = Equity 159.20b / Shares 500.3m; r=6.97% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 87.56 | EPS CAGR: 48.69% | SUE: 4.0 | # QB: 9
Revenue Correlation: 95.99 | Revenue CAGR: 29.75% | SUE: 2.22 | # QB: 1
EPS next Quarter (2026-03-31): EPS=3.31 | Chg30d=+0.270 | Revisions Net=+2 | Analysts=5
EPS current Year (2026-12-31): EPS=14.13 | Chg30d=+2.695 | Revisions Net=+4 | Growth EPS=+70.0% | Growth Revenue=+36.8%
EPS next Year (2027-12-31): EPS=13.36 | Chg30d=+2.264 | Revisions Net=+1 | Growth EPS=-5.5% | Growth Revenue=-2.9%